Abstract
A POSSIBLE LINK between lowered serum cholesterol and psychological well-being remains an issue of debate. In 1990, Muldoon et al1 in a review of 6 randomized trials found that the reductions in coronary heart disease mortality by lipid-lowering therapy were offset by a rise in noncardiovascular mortality, especially by a significant increase in deaths due to unintentional injury, suicide, or violence. Although there has been concern about the data analyzed in some trials,2 this article was followed by several observational studies3,4 and meta-analyses5,6 that indicated that lowered serum cholesterol might be associated with depression or suicide. Experiments in primates also suggested that altered dietary fat could sufficiently change brain content and lead to an increase in aggressive behavior.7 Such findings raised concern about the potential adverse psychiatric effects of lipid-lowering drugs (LLDs), because these drugs, especially 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins), are widely prescribed in daily practice. Several possible mechanisms were hypothesized to explain such an association.8